Changsha Institute of Innovation and Modernization of Traditional Chinese Medicine (general Partnership)

Using atorvastatin calcium tablets as a positive control, the efficacy and safety of Xuezhitai dispersible tablets in the treatment of hyperlipidemia (phlegm and turbidity inhibition) were explored.

Healthy subjects were selected as subjects, starting from a safe initial dose, and different dosages of Xuezhitai Dispersible Tablets were explored on healthy subjects to examine the human body's tolerance and safety, providing a safe dosage range for Phase II clinical trials.

To preliminarily evaluate the effectiveness and safety of Yangxue Runchang Granules in treating postpartum constipation (blood deficiency syndrome) in women, and to conduct exploratory research on dosage to provide a basis for Phase III clinical trials.